Dual-Purpose Mammography: Using Breast Imaging to Predict Heart Disease

The medical community is witnessing a paradigm shift in preventative screening as routine mammograms are increasingly recognized for their ability to detect early signs of cardiovascular disease. While mammography has long been the gold standard for early breast cancer detection, recent clinical evidence confirms that the presence of Breast Arterial Calcification (BAC)—calcium deposits within the breast arteries—serves as a significant red flag for heart health. This discovery transforms a standard oncological screening into a dual-purpose diagnostic tool, offering a window into a woman’s vascular health without the need for additional radiation, invasive procedures, or increased healthcare costs.

Heart disease remains the leading cause of death for women globally, yet it is frequently under-diagnosed and under-treated compared to men. Traditional risk assessments often rely on cholesterol levels, blood pressure, and age, but these metrics can miss early-stage arterial changes. BAC, which appears as white, track-like patterns on a digital mammogram, is distinct from the calcifications associated with breast cancer. Unlike the calcifications found in breast tissue, BAC occurs within the vessel walls. Research indicates that women with BAC are significantly more likely to have concurrent coronary artery calcification, the primary driver of heart attacks and strokes. By identifying these deposits during a routine breast exam, clinicians can identify high-risk patients years before a cardiac event occurs.

“

From an economic perspective, the opportunistic screening of heart disease via mammography is highly attractive.

The integration of BAC detection into standard radiology workflows represents a major opportunity for the Health IT and medical device sectors. Currently, most radiologists note the presence of BAC in their findings, but it is rarely treated with the same urgency as a suspicious mass. The emergence of artificial intelligence (AI) and machine learning in medical imaging is poised to change this. Companies specializing in Computer-Aided Detection (CAD) are developing algorithms that can automatically quantify the extent of BAC, providing a standardized score that can be shared with primary care physicians and cardiologists. This automated approach reduces the subjective variability of human interpretation and ensures that these critical cardiovascular markers are not overlooked in the high-volume environment of breast imaging centers.

However, the transition to widespread dual-screening is not without challenges. The primary hurdle is the lack of a standardized reporting and referral system. In the current fragmented healthcare landscape, a radiologist’s note about arterial calcification may never reach a patient’s cardiologist or be integrated into a cardiovascular risk calculator. To realize the full potential of this discovery, the industry must develop a framework similar to the BI-RADS (Breast Imaging-Reporting and Data System) used for cancer. Such a system would provide clear guidelines on when a BAC finding necessitates a follow-up with a heart specialist, ensuring that the data generated by the mammogram leads to meaningful clinical intervention.